GFBiochemicals

Total Funding
$16.5M
Last Round
$16.5M Series AMay 2022
Rounds
1

About

Bio-based levulinic acid and gamma-valerolactone

Summary

It has raised $16.5M in total across 1 round, most recently a $16.5M Series A round in May 2022. Investors include Sofinnova Partners and Sparta Group.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors